RMD RMD レスメド



symbol RMD
会社名 ResMed Inc. (RMD レスメド)
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 レスメド(ResMed Inc.)は持株会社である。同社は睡眠呼吸障害(SDB)、慢性閉塞性肺疾患(COPD)、神経筋疾患および呼吸器疾患を診断、治療および管理する医療機器およびクラウドベースのソフトウェアアプリケーションの開発、製造、流通および販売に従事する。SDBには、閉塞性睡眠時無呼吸(OSA)および睡眠中に生じる他の呼吸器障害が含まれる。クラウドベースのソフトウェアデジタルヘルスアプリケーションとその機器は患者のアウトカムを改善するために接続されたケアを提供するように設計される。同社の製品ポートフォリオには、機器、診断製品、マスクシステム、ヘッドギアおよびその他のアクセサリ、歯科用デバイス、ポータブル酸素濃縮器(POC)、クラウドベースのソフトウェアインフォマティクスソリューションが含まれる。同社はSDBの治療のための継続的陽性気道内圧(CPAP)、可変陽性気道内圧(VPAP)およびAutoSetシステムを製造する。  レスメドは米国の医療機器メ―カ―持株会社。子会社を通じ、睡眠呼吸障害(SDB)およびその他の呼吸器疾患を治療、診断、管理するための医療機器を開発、製造、販売。SDBは閉塞性睡眠時無呼吸(OSA)、および睡眠中に発生する他の呼吸器障害を含む。気流発生装置、診断製品、マスクシステム、ヘッドギアやその他の付属品などを取り扱う。本社はサンディエゴ。  ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
本社所在地 9001 Spectrum Center Blvd. San Diego CA 92123 USA
代表者氏名 Robert Andrew Douglas
代表者役職名 President Chief Operating Officer
電話番号 +1 858-746-2400
設立年月日 34394
市場名 NYSE(ニューヨーク証券取引所)
従業員数 5940人
url www.resmed.com
EBITDA EBITDA(百万ドル) 748.78800
時価総額 時価総額(百万ドル) 14898.90000
売上高 売上高(百万ドル) 2454.64300
企業価値(EV) 企業価値(EV)(百万ドル) 15946.91000
当期純利益 当期純利益(百万ドル) 462.88200
決算概要 決算概要 BRIEF: For the six months ended 31 December 2018 ResMed Inc. revenues increased 10% to $1.24B. Net income before extraordinary items increased 4% to $231.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling general and administrative increase of 4% to $308.9M (expense) Interest income decrease of 83% to $1.6M (income).



   Actigraphy Sensors & PSG Devices Market to reach USD 1.4 billion by 2027 | Resmed, Somno medics, Cidelec, Nox medicals  2021/10/04 19:05:00 iCrowdNewswire
Global Actigraphy Sensors & PSG Devices Market Size study, By Product Type (Actigraphy Devices, Polysomnography Devices), By Technology (Wireless USB GPS Others) and Regional Forecasts 2021-2027, The Actigraphy Sensors & PSG Devices market research report added by Report Ocean, []
   Nursing Homes and Long-Term Care Facilities Market to Eyewitness Massive Growth by 2027 | Top Key Players Allscripts, Cerner, CVS Health, Omnicell, ResMed, McKesson, MatrixCare  2021/10/04 11:18:57 OpenPR
Overview of Global Nursing Homes and Long-Term Care Facilities Market: Todays businesses choose the market research report solution such as Nursing Homes and Long-Term Care Facilities Market report because it lends a hand with the improved decision making and more revenue
   ICU Devices Market Trending Technologies, Remarkable Developments and Key Players like GE, BD, Baxter, Stryker, ResMed, Siemens, ICU Medical | Foreseen Till 2027  2021/09/29 13:44:52 OpenPR
Overview of Global ICU Devices Market: The Global ICU Devices Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players.
   Sleep Apnea Devices Market Size 2021 Demand, Business strategy, Statistics and Research Methodology ||Philips Healthcare, Lowenstein Medical Technology, ResMed, Philips Healthcare, Carefusion||  2021/09/29 10:11:27 OpenPR
The information made available in the Sleep Apnea Devices report will definitely facilitate to increase the knowledge and decision-making skills of the business, thus providing an immense opportunity for growth. This will at last increase the return rate and
   Top broker says ResMed (ASX:RMD) share price is a buy  2021/09/28 21:14:36 The Motley Fool Australia
This sleep treatment company''s shares could be in the buy zone The post Top broker says ResMed (ASX:RMD) share price is a buy appeared first on The Motley Fool Australia .
   Resmed Inc (RMD) President and COO ResMed Inc. Robert Andrew Douglas Sold $2 million of Shares  2021/07/17 03:15:07 GuruFocus
Related Stocks: RMD ,
   Western Financial Corporation Buys iShares 1-3 Year Credit Bond ETF, Tesla Inc, Square Inc, ...  2021/07/17 00:38:02 GuruFocus
Related Stocks: IGSB , ESGU , GOVT , DBX , FITB , TSLA , SQ , EPAM , EXPD , FALN , MED , NFLX , QCOM , CRM , DOCU , ETSY , RMD ,
   ResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021  2021/07/15 20:05:00 Intrado Digital Media
SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2021 on Thursday, August 5, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
   Resmed Inc (RMD) CFO Brett Sandercock Sold $621,150 of Shares  2021/07/14 18:15:02 GuruFocus
Related Stocks: RMD ,
   Continuous Positive Airway Pressure Devices Market Still Has Room To Grow: Medtronic, ResMed, Cardinal Health  2021/07/14 15:14:28 Tramways Monthly
Advance Market Analytics published a new research publication on Continuous Positive Airway Pressure Devices Market Insights, to 2026 with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Continuous Positive []

 関連キーワード  (先端医療機器_テクノロジ― 米国株 RMD レスメド RMD )


 twitter  (公式ツイッターやCEOツイッターなど)